<?xml version="1.0" encoding="UTF-8"?>
<p id="Par33">Other therapies focus on the restoration of enzyme function, thus increasing glucocerebrosidase activity, especially in the brain. This can be achieved by [3)] ERT (enzyme replacement therapy), [9)] gene therapy, or [7)] small molecules. ERT is currently available for patients with Gaucher disease. However, ERT is based on large molecules and we are not familiar with any clinical trials of ERT that may penetrate the bloodâ€“brain barrier. Furthermore, there are no data on the use of ERT in PD.</p>
